Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma
Lihua Xie(Wenzhou Medical University), Thilo Hackert(Universität Hamburg)
Cited by 15
Related Papers
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|502
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial
|The Lancet|2017|170
Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies
|Cancers|2019|92